Clinico-epidemiological Profile of COVID-19 Associated Invasive Fungal Rhinosinusitis Reported in the Teaching Hospital of Diwaniya, Qadisiya Province, Iraq: A Case Series

Ali Abd-Almer Jwad; Mohanad Jawad

Ali Abd-Almer Jwad Department of Surgery, College of Medicine, University of Al-Qadisiyah, Iraq.
Mohanad Jawad Al-Manara College for Medical Sciences, South Iraq.

Keywords: Invasive Fungal Infection, Corona, Mucormycosis, Steroid

Abstract

Introduction: With the current COVID-19 pandemic, the increasing use of glucocorticoids has resulted in more adverse effects and secondary bacterial or fungal infections.

Objective: To find out the clinic-epidemiological profile of patients having COVID-19 associated invasive fungal rhinosinusitis in Diwaniya teaching hospital- Qadisiya province - Iraq.

Method: Retrospective case series study of 24 patients with COVID-19 who were admitted to Alshafa centre in Al-Diwaniyah Province from 1st of May 2020 to end of August 2021. Patients were moderate to severe COVID-19 received treatment according to local guidelines. Patients who developed signs and symptoms of nose and paranasal sinuses disorder were seen by otolaryngologists and treated by a multidisciplinary team if invasive mucormycosis and its comorbidities were detected.

Results: Out of 24 patients, 8 were female and two patients were excluded because their histopathological examination hasnâ€™t confirmed acute invasive fungal rhinosinusitis. The average age was 54 years old, they all had diabetes, 2 patients had chronic kidney diseases, and 2 patients had malignancy (leukaemia). Furthermore, 19 patients were with severe SARS-COV-2 while 5 patients had moderate symptoms. All patients were confirmed COVID-19 positive by PCR test.

Conclusion: Invasive fungal infections of the nose and paranasal sinuses are highly lethal conditions with significant morbidity. Early recognition and high index of suspicion are needed in the case of COVID-19 patients who complain features of sinusitis with careful prescription of drugs that affect immune response in COVID-19 patients.

How to cite this article:
Jwad AAA, Jawad M. Clinico-epidemiological Profile of COVID-19 Associated Invasive Fungal Rhinosinusitis Reported in the Teaching Hospital of Diwaniya, Qadisiya Province, Iraq: A Case Series. Special Issue - COVID-19 & Other Communicable Disease. 2022;36-40.

DOI: https://doi.org/10.24321/0019.5138.202206

References

Chakrabarti A, Denning DW, Ferguson BJ, Ponikau J, Buzina W, Kita H, Marple B, Panda N, Vlaminck S, Kauffmann-Lacroix C, Das A, Singh P, Taj-Aldeen SJ, Kantarcioglu AS, Handa KK, Gupta A, Thungabathra M, Shivaprakash MR, Bal A, Fothergill A, Radotra BD. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope. 2009 Sep;119(9):1809-18. [PubMed] [Google Scholar]

Gillespie MB, Oâ€™Malley BW. An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient. Otolaryngol Clin North Am. 2000 Apr;33(2):323-34. [PubMed] [Google Scholar]

Mirza N, Lanza DC. Diagnosis and management of rhinosinusitis before scheduled immunosuppression: a schematic approach to the prevention of acute fungal rhinosinusitis. Otolaryngol Clin North Am. 2000 Apr;33(2):313-21. [PubMed] [Google Scholar]

Chopra H, Dua K, Malhotra V, Gupta RP, Puri H. Invasive fungal sinusitis of isolated sphenoid sinus in immunocompetent subjects. Mycoses. 2006 Jan;49(1):30-6. [PubMed] [Google Scholar]

Gillespie MB, Oâ€™Malley BW Jr, Francis HW. An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host. Arch Otolaryngol Head Neck Surg. 1998 May;124(5):520-6. [PubMed] [Google Scholar]

deShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Eng J Med. 1997 Jul;337(4):254-9. [PubMed] [Google Scholar]

Luna B, Drew RH, Perfect JR. Agents for treatment of invasive fungal infections. Otolaryngol Clin North Am. 2000 Apr;33:277-99. [PubMed] [Google Scholar]

Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, Puri GD, Chakrabarti A, Agarwal R. Coronavirus disease (COVID-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021 May;186(2):289-98. [PubMed] [Google Scholar]

Uckay I, Chalandon Y, Sartoretti P, Rhoner P, Berney T, Hadaya K, van Delden C. Invasive zygomycosis in transplant recipients. Clin Transplant. 2007 Jul-Aug;21(4):577-82. [PubMed] [Google Scholar]

Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses. 2007 Jul;50(4):290-6. [PubMed] [Google Scholar]

John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021 Apr;7(4):298. [PubMed] [Google Scholar]

Sen M, Lahane S, Lahane TP, Parekh R, Honavar S. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021;69(2):244-52. [PubMed] [Google Scholar]